Increment Antimicrobial Resistance During the COVID-19 Pandemic: Results from the Invifar Network.
López-Jácome LE, Fernández-Rodríguez D, Franco-Cendejas R, Camacho-Ortiz A, Morfin-Otero MDR, Rodríguez-Noriega E, Ponce-de-León A, Ortiz-Brizuela E, Rojas-Larios F, Velázquez-Acosta MDC, Mena-Ramírez JP, Rodríguez-Zulueta P, Bolado-Martínez E, Quintanilla-Cazares LJ, Avilés-Benítez LK, Consuelo-Munoz S, Choy-Chang EV, Feliciano-Guzmán JM, Couoh-May CA, López-Gutiérrez E, Molina-Jaimes A, Rincón-Zuno J, Gil-Veloz M, Alcaraz-Espejel M, Corte-Rojas RE, Gómez-Espinosa J, Monroy-Colin VA, Morales-de-la-Peña CT, Aguirre-Burciaga E, López-Moreno LI, Martínez-Villarreal RT, Cetina-Umaña CM, Galindo-Méndez M, Soto-Nieto GI, Cobos-Canul DI, Moreno-Méndez MI, Tello-Gómez E, Romero-Romero D, Quintana-Ponce S, Peralta-Catalán R, Valadez-Quiroz A, Molina-Chavarría A, Padilla-Ibarra C, Barroso-Herrera-Y-Cairo IE, Duarte-Miranda LS, López-López DM, Escalante-Armenta SP, Osorio-Guzmán MJ, López-García M, Garza-Ramos U, Delgado-Enciso I, Garza-González E.
López-Jácome LE, et al. Among authors: morfin otero mdr.
Microb Drug Resist. 2022 Mar;28(3):338-345. doi: 10.1089/mdr.2021.0231. Epub 2021 Dec 6.
Microb Drug Resist. 2022.
PMID: 34870473